Pfizer Inc. (PFE) Stock Price

PFEStock
$28.57+8.08%52W
Market Cap$162.84B
P/E19.63x
PEG Ratio2.74
Div yield5.38%
Beta0.27

PFE Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-9.05%
Price vs S&P 500 (4W)7.72%
PEG Ratio2.74
VGM Score52.62
P/E Ratio (Annual)19.63x
Indicated Dividend Yield (Annual)5.38%

PFE Earnings Surprise History

Q2 250.78est. 0.57
Q3 250.87est. 0.63
Q4 250.66est. 0.57
Q1 260.75est. 0.72
Q2 260.77est. 0.68

PFE Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
3.47
3.47
3.50
3.47

Industry Peers — Pharmaceuticals(571)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
PFEPfizer Inc.
CDC$28.57
LLYEli Lilly & Co.DBB$1233.66
JNJJohnson & JohnsonDCB$273.14
ABBVABBVIE INC.DCB$265.79
MRKMerck & Co., Inc.DCA$156.45
NVSNovartis AGCCC$159.98
AZNAstraZeneca PLCCBC$169.66
NVONovo-Nordisk A/SBCC$48.66
ABTAbbott LaboratoriesCCB$116.13
VRTXVertex Pharmaceuticals IncDCB$552.85
BMYBristol-Myers Squibb Co.BBB$67.92

About Pfizer Inc.

Pfizer is among the world's largest pharmaceutical companies with approximately $60 billion in annual sales, primarily from prescription drugs and vaccines. Key revenue drivers include blockbuster therapies Prevnar 13, Vyndaqel, and Eliquis, with international markets—particularly emerging economies—accounting for 40% of total sales.